Eric Lefkofsky is one of the country’s leading medical philanthropists. After having successfully founded a string of major internet startups, the billionaire decided to dedicate much of his time and wealth to the improvement of medicine throughout the United States. In Chicago alone, Lefkofsky is famous for having donated tens of millions of dollars to local charities, hospitals and other medical causes. He is widely credited with being one of the godfathers of modern Chicago medicine.
But over the last decade, Lefkofsky slowly began tiring of being constrained to the sidelines. After a family member was diagnosed with cancer, Lefkofsky was dismayed to find that, over the course of two years of attending oncology appointments, it was clear that many positions had less access to quality data and analytics than the typical truck driver. Lefkofsky knew that this presented a major inefficiency in the treatment of cancer and other medical conditions. He sought to begin finding ways to improve the ability of treating physicians to access quality data and intelligence in their treatment of patients.
Lefkofsky was always abreast of the cutting edge of medical research. He knew that over the last 20 years, the major area in which great advancements had been seen in cancer treatment was in the broad category of treatments known as targeted cancer therapies. These treatments were meant to reduce the side effects, often horrible, of chemotherapy, radiation and surgery, while simultaneously increasing the effectiveness of treatments. In many different areas of targeted cancer therapy, great advancements have been made in the survivability of many different types of cancer, and these had been radically improved due to the advent of targeted therapies and learn more about Eric.
This is one of the realizations that lead Lefkofsky to co-found medical data and analytics company Tempus. Tempus seeks to harvest the vast quantity of data currently available to the medical community, including the increasingly available data on individual human genomes, to allow physicians to answer complex questions regarding the treatment of different types of cancer.
Through advanced analytic techniques, Tempus is creating platforms that allow physicians to have the power of million-dollar studies at their fingertips, even for questions that have never even been considered by peer-reviewed studies and more information click here.
More Visit: https://www.facebook.com/eplefkofsky/